Among the 43 patients who underwent next-generation sequencing (NGS) analysis with matched diagnosis and bridging treatment data, 31 patients (72.1%) demonstrated a decreasing trend in VAF, with a reduction exceeding 45% from the baseline ( Figure 2C ).
← all excerpts
Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study.
1
—
—